In 2020 and 2021, nearly 5,000 clinical trials were launched to test life-saving treatments and vaccines for the novel coronavirus.
These Covid-19 clinical trials saw enrollment levels that were 80% higher than average. However, for many diseases, such as cancer, less than 10% of eligible patients enroll in a trial. Many patients only enroll in a drug trial when existing forms of treatments have already failed.